,
Zeinomar, Nur
Knight, Julia A.
Genkinger, Jeanine M.
Phillips, Kelly-Anne
Daly, Mary B.
Milne, Roger L.
Dite, Gillian S.
Kehm, Rebecca D.
Liao, Yuyan
Southey, Melissa C.
Chung, Wendy K.
Giles, Graham G.
McLachlan, Sue-Anne
Friedlander, Michael L.
Weideman, Prue C.
Glendon, Gord
Nesci, Stephanie
Andrulis, Irene L.
Buys, Saundra S.
John, Esther M.
MacInnis, Robert J.
Hopper, John L.
Terry, Mary Beth http://orcid.org/0000-0002-4106-5033
Funding for this research was provided by:
National Institutes of Health (1RO1CA159868)
National Cancer Institute (UM1 CA164920, T32-CA009529)
Cancer Australia (809195)
Australian National Breast Cancer Foundation (IF 17 kConFab)
National Health and Medical Research Council (454508, 288704, 145684)
National Breast Cancer Foundation (PRAC-17-004)
National Center for Advancing Translational Sciences (TL1TR001875)
Article History
Received: 13 June 2019
Accepted: 15 October 2019
First Online: 28 November 2019
Ethics approval and consent to participate
: All participants in the BCFR and kConFab provided written informed consent before participation. Human research ethics committees at the participating institutions granted ethics approval for the six sites of the BCFR and for kConFab:
: Not applicable
: The authors declare that they have no competing interests.